BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci 2021;22:2007. [PMID: 33670490 DOI: 10.3390/ijms22042007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kudela E, Liskova A, Samec M, Koklesova L, Holubekova V, Rokos T, Kozubik E, Pribulova T, Zhai K, Busselberg D, Kubatka P, Biringer K. The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer. EPMA J 2021;12:199-220. [PMID: 34194585 DOI: 10.1007/s13167-021-00244-3] [Reference Citation Analysis]
2 Dębiec-Bąk A, Skrzek A, Podbielska H, Golubnitschaja O, Stefańska M. Superficial temperature distribution patterns before and after physical activity in school children are indicative for personalized exercise coaching and disease prevention. EPMA J 2021;12:435-47. [PMID: 34950250 DOI: 10.1007/s13167-021-00262-1] [Reference Citation Analysis]
3 Mazurakova A, Koklesova L, Samec M, Kudela E, Sivakova J, Pribulova T, Pec MJ, Pec M, Kello M, Büsselberg D, Golubnitschaja O, Gaspar L, Caprnda M, Adamek M, Prosecky R, Eminova E, Baranenko D, Kruzliak P, Kubatka P, Biringer K. Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension 2022;29:72-85. [DOI: 10.1016/j.preghy.2022.06.007] [Reference Citation Analysis]
4 Tan T, Li J, Luo R, Wang R, Yin L, Liu M, Zeng Y, Zeng Z, Xie T. Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review. Molecules 2021;26:5792. [PMID: 34641334 DOI: 10.3390/molecules26195792] [Reference Citation Analysis]
5 Zhou Z, Long H, Xu S, Li F, Cheng Y, Luo H, Gao L. Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways. Front Pharmacol 2022;13:899208. [DOI: 10.3389/fphar.2022.899208] [Reference Citation Analysis]
6 Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Büsselberg D, Podbielska H, Kunin AA, Evsevyeva ME, Shapira N, Paul F, Erb C, Dietrich DE, Felbel D, Karabatsiakis A, Bubnov R, Polivka J, Polivka J Jr, Birkenbihl C, Fröhlich H, Hofmann-Apitius M, Kubatka P. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J 2021;:1-22. [PMID: 34422142 DOI: 10.1007/s13167-021-00251-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhou Q, Yao S, Yang M, Guo Q, Li Y, Li L, Lei B. Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber’s hereditary optic neuropathy patients. Front Neurosci 2022;16:917348. [DOI: 10.3389/fnins.2022.917348] [Reference Citation Analysis]
8 Koklesova L, Mazurakova A, Samec M, Kudela E, Biringer K, Kubatka P, Golubnitschaja O. Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00281-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Koklesova L, Liskova A, Samec M, Zhai K, Al-Ishaq RK, Bugos O, Šudomová M, Biringer K, Pec M, Adamkov M, Hassan STS, Saso L, Giordano FA, Büsselberg D, Kubatka P, Golubnitschaja O. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention. Int J Mol Sci 2021;22:8649. [PMID: 34445360 DOI: 10.3390/ijms22168649] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B, Siddiqui M, Biringer K, Kudela E, Pec M, Gadanec LK, Šudomová M, Hassan STS, Zulli A, Shakibaei M, Giordano FA, Büsselberg D, Golubnitschaja O, Kubatka P. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J 2021;:1-22. [PMID: 34025826 DOI: 10.1007/s13167-021-00242-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hu H, Yang W, Liang Z, Zhou Z, Song Q, Liu W, Deng X, Zhu J, Xing X, Zhong B, Wang B, Wang S, Shao Z, Zhang Y. Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy. J Nanobiotechnology 2021;19:221. [PMID: 34315494 DOI: 10.1186/s12951-021-00933-1] [Reference Citation Analysis]
12 Kubatka P, Mazurakova A, Samec M, Koklesova L, Zhai K, Al-ishaq R, Kajo K, Biringer K, Vybohova D, Brockmueller A, Pec M, Shakibaei M, Giordano FA, Büsselberg D, Golubnitschaja O. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways. EPMA Journal 2021;12:559-87. [DOI: 10.1007/s13167-021-00257-y] [Reference Citation Analysis]
13 Anghelescu A, Onose G, Popescu C, Băilă M, Stoica S, Postoiu R, Brumă E, Petcu I, Ciobanu V, Munteanu C. Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment. Biomedicines 2022;10:1000. [DOI: 10.3390/biomedicines10051000] [Reference Citation Analysis]
14 Wang W, Yan Y, Guo Z, Hou H, Garcia M, Tan X, Anto EO, Mahara G, Zheng Y, Li B, Kang T, Zhong Z, Wang Y, Guo X, Golubnitschaja O; Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2021;:1-31. [PMID: 34539937 DOI: 10.1007/s13167-021-00253-2] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Golubnitschaja O, Kubatka P, Mazurakova A, Samec M, Alajati A, Giordano FA, Costigliola V, Ellinger J, Ritter M. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers 2022;14:675. [DOI: 10.3390/cancers14030675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 de Holanda GS, Dos Santos Valença S, Carra AM, Lichtenberger RCL, de Castilho B, Franco OB, de Moraes JA, Schanaider A. Translational Application of Fluorescent Molecular Probes for the Detection of Reactive Oxygen and Nitrogen Species Associated with Intestinal Reperfusion Injury. Metabolites 2021;11:802. [PMID: 34940560 DOI: 10.3390/metabo11120802] [Reference Citation Analysis]
17 Koklesova L, Samec M, Liskova A, Zhai K, Büsselberg D, Giordano FA, Kubatka P, Golunitschaja O. Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine. EPMA J 2021;:1-14. [PMID: 33686350 DOI: 10.1007/s13167-021-00237-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]